Lysogene Awarded Innovation Passport by the UK MHRA for the GM1 Gangliosidosis Program
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
A look at the key developments across the sector this year - Magazine Article - PharmaTimes
Read the latest MHRA headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on MHRA...
Innovation Passport Designation Awarded to Imetelstat for the Treatment of Lower Risk Myelodysplastic Syndromes Pathway Intended to Expedite Regulatory Review Process Geron Corporation (Nasdaq:
Provides roadmap to commercial agreement based on shared objective to secure patient access to innovative and cost-effective cancer medicines Agreement with one of the largest public healthcare